Oncology 1

A 75-year-old woman presents to the physician with a new left breast mass. She has a history of type 2 diabetes mellitus and tobacco use. She takes metformin and glipizide. Ultrasound confirms the presence of a mass, and a biopsy confirms the presence of breast cancer with is human epidermal factor receptor 2 (HER2) positive. Further evaluation reveals the presence of metastatic disease. Her oncologist recommends initiation of neoadjuvant chemotherapy plus trastuzumab (Herceptin).

Which of the following side effects is most likely with trastuzumab?

  • Hepatotoxicity
  • Cardiotoxicity
  • Nephrotoxicity
  • Neurotoxicity
  • Pulmonary toxicity

Question Details